Trimix: what it is, and what compounded means for it

Trimix is an injection used for erectile dysfunction, given directly into the side of the penis. It is a mixture of three medicines, and it works for many men when tablets do not.

It is also a compounded product, not an FDA approved one, and almost nothing written about it explains what that means. That is the gap this page fills.

What is actually in it

Trimix combines three drugs that widen blood vessels and relax smooth muscle:

• Alprostadil, a prostaglandin
• Papaverine, a vasodilator
• Phentolamine, an alpha blocker

The combination is the point. Each works by a different mechanism, so together they can produce an erection at lower doses of each than any one alone would need.

There are single-agent alprostadil products that are FDA approved. Trimix, as a three-drug mixture, is not. It exists because a pharmacy compounds it.

Does injection therapy work

This part has a genuinely long record, and it is worth separating from Trimix specifically.

Intracavernosal injection therapy has been in clinical use since the early 1980s. A 2024 review in Sexual Medicine Reviews traces that history across four decades. Long-term studies report meaningful efficacy and patient satisfaction, including a 2019 study in the International Journal of Impotence Research on long-term injection therapy outcomes.

It is also one of the standard options when oral medicines fail, and there is a systematic review of its use in men with spinal cord injury.

The honest summary: injection therapy as a category has a substantial evidence base. Trimix is a specific compounded formulation within that category, and formulations vary between pharmacies.

What "compounded" actually means

This is the part that matters and that almost nobody explains.

A compounded medicine is prepared by a pharmacy rather than manufactured by a company that took it through FDA approval. The pharmacy is licensed. The specific medicine in the vial is not reviewed by the FDA for safety, effectiveness or quality before it reaches you.

Federal law recognises two kinds of compounder:

• Section 503A: a state licensed pharmacy compounding for an individual patient with a prescription. Regulated mainly by the state board of pharmacy. Not required to follow federal manufacturing quality rules.
• Section 503B: a registered outsourcing facility that may compound in batches, must follow federal manufacturing quality standards, and is subject to FDA inspection.

Both come from the Drug Quality and Security Act of 2013, at 21 U.S.C. 353a and 353b.

Neither produces an FDA approved medicine. Registration is not approval, and inspection is not approval. The FDA has said directly that compounding facilities "are not 'FDA-approved' or 'FDA-licensed' entities."

Why that matters for Trimix specifically

Concentration varies. Trimix is not one recipe. Different pharmacies use different ratios and strengths, and some offer variants with a fourth agent. A dose that is right from one pharmacy is not automatically right from another. If your pharmacy changes, treat the dose as a new conversation with your prescriber, not a refill.

Storage matters. These are refrigerated preparations with a limited shelf life. Ask how yours should be stored and how long it is good for.

Who made it is a real question. Ask which pharmacy or outsourcing facility compounds yours, whether they are registered with the FDA as an outsourcing facility, and whether they are licensed in your state. The FDA publishes a list of registered outsourcing facilities and state boards publish licence lookups.

Watch the marketing language. The FDA has published specific claims that companies must not make about compounded drugs, including calling a compounded product FDA approved, describing it as a generic version of an approved drug, or describing the source as an "FDA approved" or "FDA licensed" pharmacy. Those are the same rules that apply to compounded weight-loss drugs, and they apply here.

The risks specific to injection therapy

This is a real medical procedure and it has real risks that your prescriber should walk you through, including prolonged erection, pain at the injection site, and scarring with repeated use. A prolonged erection is a medical emergency and you should know in advance what to do and who to call.

We are not going to give dosing guidance. That is between you and a clinician who examines you, and first doses of injection therapy are usually given in a clinical setting for good reason.

What to ask before you start

• Which pharmacy compounds this, and are they registered with the FDA?
• What is the exact concentration of each of the three agents in my prescription?
• Will my first dose be given in a clinic?
• How should I store it and how long does it last?
• What do I do, and who do I call, if an erection lasts too long?
• What happens to my dose if the pharmacy or the formulation changes?

One thing worth raising separately

Erectile dysfunction is an independent predictor of future cardiovascular events, according to a 2018 analysis in Circulation from the Multi-Ethnic Study of Atherosclerosis. Treating the symptom does not investigate the cause. If nobody has looked at your vascular and metabolic health, that is a conversation worth having.

Sources

• Federal Food, Drug, and Cosmetic Act sections 503A and 503B, 21 U.S.C. 353a and 353b
• Drug Quality and Security Act, Public Law 113-54 (2013)
• FDA, "FDA to Telehealth Companies: What to Know When Promoting Compounded Drugs"
• A comprehensive history of injection therapy for erectile dysfunction, 1982-2023. Sexual Medicine Reviews, 2024. doi:10.1093/sxmrev/qeae020
• Long-term intracavernosal injection therapy: treatment efficacy and patient satisfaction. International Journal of Impotence Research, 2019. doi:10.1038/s41443-019-0186-z
• Intracavernous injections in spinal cord injured men with erectile dysfunction: a systematic review. Sexual Medicine Reviews, 2016. doi:10.1016/j.sxmr.2016.02.005
• Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis. Circulation, 2018. doi:10.1161/CIRCULATIONAHA.118.033990

How we verify: see /how-we-verify.

Keep reading

How injection therapy works and who it is for, at /guides/ed-injections.

What the placebo-controlled trials found for the P-Shot, at /guides/p-shot.